PHE - Corporate - Evidence Map on Biotinidase Deficiency
Estimated value
—
Awarded value
£6k
Awarded 06 Jun 2021
Suppliers
1
Lots
1
1 awarded
Published
09 Jun 2021
Deadline 02 Jun 2021
Other contracts from Public Health England· 10
Most recent notices published by the same contracting authority.
| Title | Type | Value | Published |
|---|---|---|---|
| PHE_Scientific_Provision for purchase of various bespoke Covid-19 surveillance kits | contract | — | 21 Jan 2021 |
| PHE_Scientific__Provision for purchase of tubes and screw caps for Covid | contract | — | 21 Jan 2021 |
| Call off of Framework for Print Services. | contract | — | 21 Jan 2021 |
| Provision of Combined IgG/IgM Elisa kits | contract | — | 21 Jan 2021 |
| PHE_Scientific Provision for Purchase of autoclave vent filter testing apparatus | contract | — | 21 Jan 2021 |
| Purchase of Liquid handling robot for Vaccines and antivirals Covid-19 work | contract | £20k | 21 Jan 2021 |
| PHE_Scientific__Provision for purchase of tubes and screw caps for Covid | contract | £181k | 21 Jan 2021 |
| Professional APHA Veterinary Support Expertise | contract | £60k | 21 Jan 2021 |
| Provision of Operational Support Services | contract | £3.8m | 21 Jan 2021 |
| PHE - ICT - Occupational Health software licensing 2020 on-wards gCloud | contract | £38k | 21 Jan 2021 |
Other contracts awarded to Costello Medical Consulting Ltd· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| Health Economics Feasibility Study- Specialised Commissioning | contract | £24k | 17 Oct 2023 |
| C149851_DHSC: OHID: Anorectal malformations Evidence Map | contract | £17k | 24 Mar 2023 |
| DHSC: OHID: Metachromatic Leukodystrophy (MLD) Evidence Map | contract | £16k | 20 Mar 2023 |
| Consultancy Services for Population Health Programme | contract | £44k | 29 Nov 2022 |
| Evidence Map on Screening for Cytomegalovirus | contract | £50k | 18 Jun 2021 |
| PHE - Corporate - Asymptomatic Bacteriuria Screening in Pregnancy | contract | £81k | 26 May 2021 |
| PHE - Corporate - Evidence Map on Neuronal Ceroid Lipofuscinosis Type 2 | contract | £11k | 21 Apr 2021 |
| PHE - Corporate - Screening for Duchenne Muscular Dystrophy | contract | £15k | 31 Mar 2021 |
| PHE - Corporate - A Clinical and Cost Effectiveness Model on Formalising New-born Screening for β-thalassaemia Major | contract | £81k | 03 Nov 2020 |
| PHE - Corporate - Ultrasound Screening for Fetal Presentation at 36 Weeks | contract | £11k | 02 Sept 2020 |